Envoy Medical (COCH) Free Cash Flow (2021 - 2026)

Envoy Medical (COCH) has 6 years of Free Cash Flow data on file, last reported at -$6.1 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 62.45% year-over-year to -$6.1 million; the trailing twelve-month figure through Mar 2026 stood at -$20.7 million (down 22.1% YoY), and the FY2025 full-year result was -$18.4 million, up 2.9% from the prior year.
• Free Cash Flow declined to -$6.1 million in Q1 2026, from -$5.8 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $1.0 million in Q3 2023 to a low of -$11.2 million in Q4 2023.
• A 5-year average of -$4.1 million and a median of -$4.4 million in 2025 frame the typical range for Free Cash Flow.
• Peak annual rise in Free Cash Flow reached 119.74% in 2023, while the deepest fall reached 910.85% in 2023.
• Tracing COCH's Free Cash Flow over 5 years: stood at -$2.4 million in 2022, then tumbled by 361.4% to -$11.2 million in 2023, then surged by 59.19% to -$4.6 million in 2024, then decreased by 27.45% to -$5.8 million in 2025, then retreated by 4.36% to -$6.1 million in 2026.
• Business Quant data shows COCH's Free Cash Flow at -$6.1 million in Q1 2026, -$5.8 million in Q4 2025, and -$4.4 million in Q3 2025.